NEUROSCIENTIFIC ORDINARY (NSB) Short Interest
NEUROSCIENTIFIC ORDINARY (ASX:NSB) had 0.00% of shares reported as short positions as of 11 July 2026, representing 3,800 shares. NEUROSCIENTIFIC ORDINARY operates in the Pharmaceuticals, Biotechnology & Life Sciences industry. Source: ASIC short position report (T+4 delay).
Source: official ASIC short position report, T+4 delay. Methodology · Disclaimer — not financial advice.
Unlock advanced features: Custom dashboards, portfolio tracking, real-time alerts, and more
Neuroscientific Biopharmaceuticals
NeuroScientific Biopharmaceuticals Ltd is an Australian biotechnology company focused on developing novel stem cell technologies for immune-mediated inflammatory diseases. Their patented StemSmart™ technology aims to enhance the safety and efficacy of mesenchymal stem cell (MSC) therapies, targeting conditions like Crohn's disease. The company is currently prioritizing a special access program for fistulising Crohn’s disease and plans to advance to clinical trials.